Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31K Buy
48
+11
+30% +$1.83K ﹤0.01% 1943
2026
Q1
$7.76K Buy
37
+1
+3% +$251 ﹤0.01% 1895
2025
Q4
$10.2K Sell
36
-14
-28% -$4.38K ﹤0.01% 1851
2025
Q3
$15.4K Hold
50
﹤0.01% 1743
2025
Q2
$15.7K Buy
50
+3
+6% +$866 ﹤0.01% 1755
2025
Q1
$12.3K Sell
47
-3
-6% -$812 ﹤0.01% 1809
2024
Q4
$13.1K Sell
50
-77
-61% -$19.4K ﹤0.01% 1738
2024
Q3
$25.6K Buy
127
+58
+84% +$11.9K ﹤0.01% 1848
2024
Q2
$11.8K Buy
69
+40
+138% +$7.21K ﹤0.01% 1869
2024
Q1
$4.97K Sell
29
-2
-6% -$373 ﹤0.01% 1645
2023
Q4
$5K Buy
31
+29
+1,450% +$4.97K ﹤0.01% 1858
2023
Q3
$1K Hold
2
﹤0.01% 1951
2023
Q2
$1K Sell
2
-4
-67% -$1.22K ﹤0.01% 1906
2023
Q1
$2K Sell
6
-14
-70% -$4.15K ﹤0.01% 2035
2022
Q4
$5K Sell
20
-2
-9% -$552 ﹤0.01% 1746
2022
Q3
$5K Buy
22
+18
+450% +$4.51K ﹤0.01% 1575
2022
Q2
$1K Buy
+4
New +$909 ﹤0.01% 1815

Other funds holding PODD

Blue Trust Inc's PODD Position: Q2 2026 in Review

Blue Trust Inc increased its Insulet (PODD) stake by 30% in Q2 2026, buying an estimated $1.83K and bringing the position to 48 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Blue Trust Inc first reported a position in PODD in Q2 2022 and has held it in 17 quarters since. The position peaked at $25.6K in Q3 2024. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Blue Trust Inc held 48 shares of Insulet worth $7.31K as of Q2 2026.
  • Blue Trust Inc bought 11 Insulet shares in Q2 2026, an estimated $1.83K.
  • Insulet made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1943 holding.
  • Blue Trust Inc first reported a position in Insulet in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Insulet position peaked at $25.6K in Q3 2024.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.